Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
Pfizer(PFE) stock is priced at $27.43, giving the company a market capitalization of 157.1B. It carries a P/E multiple of 20.39 and pays a dividend yield of 6.2%.
As of 2026-03-02, Pfizer(PFE) stock has fluctuated between $27.12 and $27.59. The current price stands at $27.43, placing the stock +1.1% above today's low and -0.6% off the high.
Pfizer(PFE) shares are trading with a volume of 1.47M, against a daily average of 35.29M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
PFE News
Argus upgraded Pfizer (PFE) to Buy from Hold with a $35 price target The firm is positive on the company’s recent additions to its GLP-1 pipeline along with its...
Key Points Regencell Bioscience's outrageous performance in the past year is baffling. Despite the stock's sharp rise, there is little to look forward to for...
Eli Lilly (LLY +2.93%) is growing very quickly right now thanks to Mounjaro and Zepbound, its two GLP-1 drugs, the latter of which is approved for weight loss....
Analyst ratings
59%
of 29 ratingsMore PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 50% Off TipRanks Premium Unlock hedge fund-lev...
Pfizer received full FDA approval for BRAFTOVI (encorafenib) in combination with cetuximab and fluorouracil based chemotherapy for BRAF V600E mutant metastatic...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase 1 study called “A PHASE 1, OPEN-LABEL, RANDOMIZED, S...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is launching a phase 2 study called “A PHASE 2, RANDOMIZED, DOUBLE-BLIN...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a late-stage study called Tranquillo to test an oral drug fo...
Pfizer (PFE) and Astellas Pharma (ALPMY) announced positive results from the Phase 3 EV-304 clinical trial for PADCEV, a Nectin-4 directed antibody-drug conjuga...
Pfizer secured exclusive commercialization rights to Sciwind's ecnoglutide in China for type 2 diabetes and potential obesity treatment. The company expanded i...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.